Showing results (501-510 of 516) with videos related to

Sort By:
Pageof 52
Journal of Clinical Medicine|March 29, 2023
Trends in Net Survival from Vulvar Squamous Cell Carcinoma in Italy (1990-2015)Silvia Mancini, Lauro Bucchi, Federica Zamagni, et al.
The American Journal of Gastroenterology|February 12, 2009
Serum ferritin as a predictor of treatment outcome in patients with chronic hepatitis CFrancesca Ferrara, Paolo Ventura, Alberto Vegetti, et al.
Annals of Surgery|October 26, 2012
Barrett's esophagus and adenocarcinoma risk: the experience of the North-Eastern Italian Registry (EBRA)Massimo Rugge, Giovanni Zaninotto, Paola Parente, et al.
Histopathology|August 22, 2018
Histology of portal vascular changes associated with idiopathic non-cirrhotic portal hypertension: nomenclature and definitionMaria Guido, Venancio A F Alves, Charles Balabaud, et al.
Clinical Epigenetics|December 12, 2022
LINE-1 hypomethylation is associated with poor outcomes in locoregionally advanced oropharyngeal cancerMariateresa Casarotto, Valentina Lupato, Giorgio Giurato, et al.
Expert Review of Gastroenterology & Hepatology|May 29, 2018
Acute-on-chronic liver failure 2018: a need for (urgent) liver biopsy?Dirk J van Leeuwen, Venancio Alves, Charles Balabaud, et al.
Journal of Hepatology|October 10, 2025
Consensus position statements for the standardized application of histological grading and staging systems in MASH clinical trialsCarolin Lackner, Annette S H Gouw, Venancio Avancini Ferreira Alves, et al.
Journal of Hepatology|June 14, 2021
Development and prognostic relevance of a histologic grading and staging system for alcohol-related liver diseaseCarolin Lackner, Rudolf E Stauber, Susan Davies, et al.
JHEP Reports : Innovation in Hepatology|April 25, 2026
New histopathological terminology for well-differentiated hepatocellular lesions in unusual clinico-pathological scenarios: HCA-like and FNH-likeChristine Sempoux, Venancio Af Alves, Johanna Arola, et al.
British Journal of Cancer|April 22, 2026
Inhibition of the SerpinB3/protease-activated receptor 2 axis reduces liver cancer development and affects lipid metabolismPietro Guerra, Gianmarco Villano, Claudia M Rejano-Gordillo, et al.
Pageof 52